Title : Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Pub. Date : 2019 Jan 5

PMID : 30449625






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Whether replacement of cisplatin with cetuximab-an antibody against the epidermal growth factor receptor-can preserve high survival and reduce treatment toxicity is unknown. Cisplatin epidermal growth factor receptor Homo sapiens